Wellington Management Group LLP Ascendis Pharma A/S Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Wellington Management Group LLP holds 918,095 shares of ASND stock, worth $180 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
918,095
Previous 587,763
56.2%
Holding current value
$180 Million
Previous $91.6 Million
72.98%
% of portfolio
0.03%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding ASND
# of Institutions
276Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$975 Million15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$867 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...